Column
-
The billionaire fast lane
Two distinct themes emerge from a cursory glance at the rich list: Digital and health
-
In the Crosswinds
Ajay Singh belongs to a rare breed that revels in the Herculean odds of turning around an airline
-
Rushing the big white hope of the antidote
Dr Reddy's Laboratories, risk-taker and pioneer of several new drugs and R&D has its reasons for partnering with Russia, which go way beyond the vaccine.
-
Back as bellwether?
Infosys's performance is a sign of the resilience of its strategy and operating model
-
Food and drug administration
In April-June, Britannia's net profits were up by 118% over a year ago, and at a three-year high
-
The great rural hope
If there are glimmers of hope for the economy, they're largely being seen in agrarian India
-
Born to be online
Digital-first brands have the capacity to disrupt their brick-and-mortar counterparts
-
A lighter shade of purple
If shattering of gender stereotypes needed a shot in the arm, it came during the lockdowns
-
Capitalism in Covid times
The pandemic may have deepened the chasm between the have-much and the have-little
-
Dribble and Dunk
A pivot during Covid-19 could well start out as survival gambit but end up as a huge opportunity
